Literature DB >> 4043164

Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis. Study in a north German population.

H P Hanssen, D P Agarwal, H W Goedde, H Bucher, H Huland, W Brachmann, R Ovenbeck.   

Abstract

The N-acetyltransferase phenotype was determined in 105 German patients with bladder carcinoma and in a control group of 42 healthy subjects. The slow phenotype was significantly more frequent among the patients (61.9% compared to 42.9% in the control group). Potential risk factors like occupational exposure, smoking habits, drug abuse and urological anamnestic predispositions were evaluated in relation to staging and grading of the disease, and acetylator phenotype.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043164     DOI: 10.1159/000472511

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

1.  NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

Authors:  Montserrat García-Closas; Núria Malats; Debra Silverman; Mustafa Dosemeci; Manolis Kogevinas; David W Hein; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Gemma Castaño-Vinyals; Meredith Yeager; Robert Welch; Stephen Chanock; Nilanjan Chatterjee; Sholom Wacholder; Claudine Samanic; Montserrat Torà; Francisco Fernández; Francisco X Real; Nathaniel Rothman
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

2.  Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer.

Authors:  Y Horai; K Fujita; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 3.  N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.

Authors:  D W Hein
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

4.  Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.

Authors:  Hiromasa Tsukino; Yoshiki Kuroda; Hiroyuki Nakao; Hirohisa Imai; Hisato Inatomi; Yukio Osada; Takahiko Katoh
Journal:  J Cancer Res Clin Oncol       Date:  2003-11-27       Impact factor: 4.553

Review 5.  N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction.

Authors:  J Green; E Banks; A Berrington; S Darby; H Deo; R Newton
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

Review 6.  Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis.

Authors:  Zongheng Zhu; Jinshan Zhang; Wei Jiang; Xianjue Zhang; Youkong Li; Xiaoming Xu
Journal:  Onco Targets Ther       Date:  2015-12-11       Impact factor: 4.147

Review 7.  Epidemiology of urinary bladder cancer: from tumor development to patient's death.

Authors:  Cristiane Murta-Nascimento; Bernd J Schmitz-Dräger; Maurice P Zeegers; Gunnar Steineck; Manolis Kogevinas; Francisco X Real; Núria Malats
Journal:  World J Urol       Date:  2007-06       Impact factor: 3.661

8.  Biomarkers in occupational cancer epidemiology: considerations in study design.

Authors:  R B Hayes
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.